Michael F. Berger
Papers
1
Total Citations
6
H-Index
1
About
Michael F. Berger is a pathologist and translational researcher whose work sits at the intersection of molecular diagnostics and cancer biology. His primary research focuses on developing and validating novel RNA-based biomarkers for improved tumor classification and prognosis. Berger's most significant contribution to date is his pioneering evaluation of TERT mRNA expression using RNAscope® technology, a breakthrough that offers a histopathologic diagnostic and prognostic tool for various cancers. This work, published in 2022, has already garnered 6 citations, signaling its growing influence in the field. By enabling direct visualization of TERT expression in tissue sections, Berger's approach provides a powerful alternative to traditional DNA-based assays, enhancing the accuracy of cancer diagnosis and patient stratification. His research bridges the gap between molecular biology and clinical pathology, offering practical tools for routine diagnostic workflows. Berger's dedication to translating complex molecular mechanisms into actionable clinical insights positions him as a rising authority in precision oncology, with his work promising to refine how pathologists assess tumor aggressiveness and guide therapeutic decisions.
Research Focus
Key Achievements
Top Papers
- 1